About: ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years
Creator	Bastiaannet, Esther Garioch, Jennifer Heaton, Martin Hoekstra, Harald Hoekstra-Weebers, Josette Moncrieff, Marc Patel, Nakul Underwood, Beverly
source	Medline; PMC
abstract	covid:ac1ab0dc8b5c4a6855782c8a6c871b954f1dd527#abstract
has issue date	2020-07-10(xsd:dateTime)
bibo:doi	10.1245/s10434-020-08763-5
bibo:pmid	32651698
has license	cc-by
sha1sum (hex)	ac1ab0dc8b5c4a6855782c8a6c871b954f1dd527
schema:url	https://doi.org/10.1245/s10434-020-08763-5
resource representing a document's title	ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years
has PubMed Central identifier	PMC7351550
has PubMed identifier	32651698
schema:publication	Ann Surg Oncol
resource representing a document's body	covid:ac1ab0dc8b5c4a6855782c8a6c871b954f1dd527#body_text
is schema:about of	named entity 'institutional' named entity 'Melanoma' named entity 'neutral' named entity 'Patients' named entity 'Years' named entity 'Springer Nature' named entity 'Cutaneous' named entity 'National Institutes for Health and Care Excellence' named entity 'follow-up' named entity 'SLNB' named entity 'follow-up' named entity 'follow-up' named entity 'COVID-19 pandemic' named entity 'follow-up' named entity 'Creative Commons licence' named entity 'melanoma' named entity 'follow-up' named entity 'primary endpoint' named entity 'sentinel lymph node biopsy' named entity 'AJCC' named entity 'melanoma' named entity 'follow-up' named entity 'cutaneous' named entity 'AJCC' named entity 'AJCC' named entity 'melanoma' named entity 'melanomas' named entity 'cutaneous' named entity 'Dutch' named entity 'sentinel node' named entity 'Creative Commons Attribution 4.0' named entity 'American Joint Committee on Cancer' named entity 'melanoma' named entity 'QoL' named entity 'follow-up' named entity 'secondary endpoints' named entity 'Melanoma' named entity 'melanoma' named entity 'follow-up' named entity 'disease-specific' named entity 'Creative Commons licence' named entity 'NICE' named entity 'quality of life' named entity 'modern healthcare' named entity 'mental health' named entity 'follow-up' named entity 'stage II' named entity 'melanoma' named entity 'NICE' named entity 'melanoma' named entity 'randomized controlled trial' named entity 'SLNB' named entity 'anxiety' named entity 'melanomas' named entity 'Creative Commons licence' named entity 'melanoma' named entity 'national guidelines' named entity 'follow-up' named entity 'QoL' named entity 'AJCC' named entity 'QoL' named entity 'OPEN ACCESS' named entity 'phase III' named entity 'Follow-Up' named entity 'jurisdictional claims' named entity 'Melanoma' named entity 'PUBLISHED' named entity 'MAPS' named entity 'REMAINS' named entity 'REGARD' named entity 'NOTE' named entity '27S' named entity 'PATIENTS' named entity 'ADJUSTED'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software